Search research articles
Contact Us
Filters
Showing results (601-610 of 721) with videos related to
Page
of 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 19, 2026
<sup>90</sup>Y-FAPI-46 Radiopharmaceutical Therapy in Sarcoma and Other Solid Tumors: An Updated Cohort Analysis
Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024
Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 14, 2015
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease
Ken Herrmann, Margret Schottelius, Constantin Lapa, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 12, 2017
<sup>68</sup>Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 6, 2017
Most of the Intended Management Changes After <sup>68</sup>Ga-DOTATATE PET/CT Are Implemented
Jeremie Calais, Johannes Czernin, Matthias Eiber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 20, 2022
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study
Manuel Weber, David Kersting, Burkhard Riemann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 3, 2020
Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
Hossein Jadvar, Leslie K Ballas, Peter L Choyke, et al.
Eclinicalmedicine
|
October 21, 2024
Multivariable models of outcomes with [<sup>177</sup>Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial
Ken Herrmann, Andrei Gafita, Johann S de Bono, et al.
EJNMMI Research
|
March 13, 2026
Comparison between [<sup>68</sup>Ga]Ga-FAPI-46 and [<sup>18</sup>F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancer
Alina Toni Küper, Sofia Carrilho Vaz, Kim Magaly Pabst, et al.
European Urology Open Science
|
June 26, 2023
Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimens
Christopher Darr, Pedro Fragoso Costa, Theresa Kahl, et al.
Page
of 73
Search research articles
Search
Showing results (601-610 of 721) with videos related to
Sort By:
Page
of 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 19, 2026
<sup>90</sup>Y-FAPI-46 Radiopharmaceutical Therapy in Sarcoma and Other Solid Tumors: An Updated Cohort Analysis
Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024
Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 14, 2015
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease
Ken Herrmann, Margret Schottelius, Constantin Lapa, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 12, 2017
<sup>68</sup>Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 6, 2017
Most of the Intended Management Changes After <sup>68</sup>Ga-DOTATATE PET/CT Are Implemented
Jeremie Calais, Johannes Czernin, Matthias Eiber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 20, 2022
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study
Manuel Weber, David Kersting, Burkhard Riemann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 3, 2020
Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
Hossein Jadvar, Leslie K Ballas, Peter L Choyke, et al.
Eclinicalmedicine
|
October 21, 2024
Multivariable models of outcomes with [<sup>177</sup>Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial
Ken Herrmann, Andrei Gafita, Johann S de Bono, et al.
EJNMMI Research
|
March 13, 2026
Comparison between [<sup>68</sup>Ga]Ga-FAPI-46 and [<sup>18</sup>F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancer
Alina Toni Küper, Sofia Carrilho Vaz, Kim Magaly Pabst, et al.
European Urology Open Science
|
June 26, 2023
Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimens
Christopher Darr, Pedro Fragoso Costa, Theresa Kahl, et al.
Page
of 73